Exploring the pros and cons of funder open access platforms
In a recent publication, researchers examine whether funder open access platforms are a good idea.
Open access for all scientific papers by 2020: an impossible target?
Robert-Jan Smits, a senior European Commission official comments on whether open access for all scientific papers by 2020 is a realistic goal.
In memory of Professor Doug Altman
The Publication Plan remembers Professor Doug Altman, founder of the EQUATOR network, who passed away last month.
Join CBI’s 14th Annual Publication Planning Meeting
CBI’s Publication Planning Meeting is back by popular demand with new dates and an exciting new programme.
ASCO journals now offer open access for publications of industry-sponsored research
In a recent MAP newsletter, ISMPP share an update from ASCO on their new open access option for industry-funded research.
[VIDEO] Preprints and peer review – feedback from the 14th Annual Meeting of ISMPP
Mary Yianni, Publisher at Taylor and Francis, reviews the different models of peer review and the emerging role of preprints.
New ICMJE data sharing requirements come into effect imminently
Don’t forget! From 1 July 2018, ICMJE requires all reports of clinical trial data to include a data sharing statement.
New recommendations to improve authorship transparency
How can journals, institutions, funders and societies improve and standardise the current authorship system?
Meeting report: summary of the 14th Annual Meeting of ISMPP – Part 2
Missed the 14th Annual Meeting of ISMPP? Read the second part of our meeting report to get up to speed!
Meeting report: summary of the 14th Annual Meeting of ISMPP — Part 1
Missed the 14th Annual Meeting of ISMPP? Read our meeting report to get up to speed!
Clinical trial transparency: are non-commercial funders lagging behind industry sponsors?
A new study from the AllTrials team sheds light on clinical trial reporting rates by non-industry sponsors.
A new series from The BMJ highlights unreported trials
A new, regular series in The BMJ will highlight a different unreported clinical trial every week, with the intention of improving reporting rates.
Textbooks: at risk of being biased and outdated?
Dr Richard Smith reviews the potential pitfalls of textbooks in a recent opinion piece for The BMJ.
Do preprints have a place in today’s reference lists?
Can preprints be cited in the same way as papers published in a peer reviewed journal, or do we need to define new standards?
No improvement in reporting of non-pharmacological interventions in 13 years
The CONSORT extension for reporting non-pharmacological interventions was introduced in 2008. A recent study looks at the impact of this guidance on reporting standards.
Focusing on big data: is seeing believing?
Are we too willing to accept big data as fact? Find out how scientific publishing can learn from common mistakes arising from bad data practice.